Bo Dai

841 total citations
34 papers, 547 citations indexed

About

Bo Dai is a scholar working on Surgery, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Bo Dai has authored 34 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 12 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Bo Dai's work include Tissue Engineering and Regenerative Medicine (5 papers), Epigenetics and DNA Methylation (4 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Bo Dai is often cited by papers focused on Tissue Engineering and Regenerative Medicine (5 papers), Epigenetics and DNA Methylation (4 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Bo Dai collaborates with scholars based in China, United States and India. Bo Dai's co-authors include Theodore P. Rasmussen, Namyoung Jung, Ravindra Majeti, Andrew J. Gentles, Andrew P. Feinberg, Ronald W. Millard, Yigang Wang, Wei Huang, Muhammad Ashraf and Meifeng Xu and has published in prestigious journals such as Nature Communications, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Bo Dai

29 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Dai China 12 319 128 76 66 64 34 547
Natalia Pacienza Argentina 14 304 1.0× 98 0.8× 36 0.5× 62 0.9× 120 1.9× 27 539
Yvonne W. Elderkamp Netherlands 5 497 1.6× 79 0.6× 49 0.6× 95 1.4× 32 0.5× 5 725
Hikaru Matsuda Japan 9 269 0.8× 99 0.8× 23 0.3× 96 1.5× 36 0.6× 12 546
Sergey Tkachuk Germany 16 260 0.8× 84 0.7× 89 1.2× 93 1.4× 68 1.1× 23 647
Tomáš Olejár Czechia 12 176 0.6× 51 0.4× 56 0.7× 41 0.6× 37 0.6× 39 381
Gimbrone Ma United States 7 228 0.7× 80 0.6× 65 0.9× 46 0.7× 27 0.4× 10 538
Omozuanvbo Aisiku United States 8 174 0.5× 42 0.3× 153 2.0× 46 0.7× 51 0.8× 10 543
Cristina Olgasi Italy 11 357 1.1× 111 0.9× 41 0.5× 63 1.0× 53 0.8× 21 575
Rodney S. Kawahara United States 10 361 1.1× 49 0.4× 42 0.6× 63 1.0× 37 0.6× 18 635
Shinji Tsuchida Japan 15 207 0.6× 90 0.7× 22 0.3× 36 0.5× 22 0.3× 48 503

Countries citing papers authored by Bo Dai

Since Specialization
Citations

This map shows the geographic impact of Bo Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Dai more than expected).

Fields of papers citing papers by Bo Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Dai. The network helps show where Bo Dai may publish in the future.

Co-authorship network of co-authors of Bo Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Dai. A scholar is included among the top collaborators of Bo Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Dai. Bo Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
4.
Zhang, Cheng, Han Du, Bo Dai, et al.. (2024). Synergistic effects of Lianhuaqingwen in combination with Oseltamivir and Baloxavir against seasonal influenza virus: In vitro and in vivo assessment. Journal of Ethnopharmacology. 338(Pt 2). 119091–119091. 1 indexed citations
5.
Dai, Bo, et al.. (2022). Advantages of using indocyanine green in liver transplantation: a narrative review. Annals of Translational Medicine. 10(2). 110–110. 3 indexed citations
6.
Tang, Xinlong, Yi Jiang, Yunxing Xue, et al.. (2021). Predictive Factors for In-Hospital Preoperative Rupture in Hyperacute Type A Aortic Dissection. The Heart Surgery Forum. 24(2). E379–E386. 3 indexed citations
7.
Xie, Huyang, Yiping Zhu, Guohai Shi, et al.. (2019). Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer. Frontiers in Oncology. 9. 856–856. 16 indexed citations
9.
Shi, Yunying, Lin Yan, Yang Bai, et al.. (2018). Soluble Tim-3 and Gal-9 are associated with renal allograft dysfunction in kidney transplant recipients: A cross-sectional study. International Immunopharmacology. 55. 330–335. 18 indexed citations
10.
Liu, Xianhua, et al.. (2018). Nicotinic acid and related compounds. Medicine. 97(12). e0117–e0117. 5 indexed citations
11.
Yan, Lin, Yi Li, Jiangtao Tang, et al.. (2016). The influence of living donor SHROOM3 and ABCB1 genetic variants on renal function after kidney transplantation. Pharmacogenetics and Genomics. 27(1). 19–26. 5 indexed citations
12.
Jung, Namyoung, Bo Dai, Andrew J. Gentles, Ravindra Majeti, & Andrew P. Feinberg. (2015). An LSC epigenetic signature is largely mutation independent and implicates the HOXA cluster in AML pathogenesis. Nature Communications. 6(1). 8489–8489. 105 indexed citations
13.
14.
Dai, Bo, Charles Giardina, & Theodore P. Rasmussen. (2012). Quantitation of Nucleosome Acetylation and Other Histone Posttranslational Modifications Using Microscale NU-ELISA. Methods in molecular biology. 981. 167–176. 11 indexed citations
15.
Dai, Bo, et al.. (2011). Detection of Post-translational Modifications on Native Intact Nucleosomes by ELISA. Journal of Visualized Experiments. 4 indexed citations
16.
Huang, Wei, Tao Wang, Dongsheng Zhang, et al.. (2011). Mesenchymal Stem Cells Overexpressing CXCR4 Attenuate Remodeling of Postmyocardial Infarction by Releasing Matrix Metalloproteinase-9. Stem Cells and Development. 21(5). 778–789. 47 indexed citations
17.
Zhu, Yi-Ping, Yijun Shen, Ding-Wei Ye, et al.. (2011). Narrow-Band Imaging Flexible Cystoscopy in the Detection of Clinically Unconfirmed Positive Urine Cytology. Urologia Internationalis. 88(1). 84–87. 12 indexed citations
18.
Dai, Bo, Wei Huang, Meifeng Xu, et al.. (2011). Reduced Collagen Deposition in Infarcted Myocardium Facilitates Induced Pluripotent Stem Cell Engraftment and Angiomyogenesis for Improvement of Left Ventricular Function. Journal of the American College of Cardiology. 58(20). 2118–2127. 50 indexed citations
19.
20.
Yao, Xuan, et al.. (2009). 255 MENSTRUATIONS WERE ALTERED BY SORAFENIB IN FEMALE PATIENTS WITH ADVANCED RENAL CELL CARCINOMA: THE POSSIBLE MECHANISM. European Urology Supplements. 8(4). 184–184. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026